Patent ID: 8329675

Claim:
A method for treating a fatty acid amide hydrolase (FAAH) mediated disorder comprising administering to a subject having the FAAH medicated disorder a therapeutically effective amount of a compound having the following formula: or a pharmaceutically acceptable salt thereof, wherein: Z 1 and Z 2 , independently, are hydroxy, alkoxy, aryloxy, or aralkyloxy; or Z 1 and Z 2 taken together with B form a ring structure derived from two hydroxyl groups separated by a least two carbon atoms, wherein said ring structure comprising optionally one or more heteroatoms independently selected from the group consisting of N, S, and O; n is 1, 2, 3, or 4; m is 1 or 2; X is a bond, O, S, NR 3 , CR 4 R 5 , OCR 4 R 5 , CR 4 R 5 O, SCR 4 R 5 , CR 4 R 5 S, NR 3 CR 4 R 5 , or CR 4 R 5 NR 3 ; R 1 is, independently at each occurrence, halide, alkyl, perhaloalkyl, alkoxy, or trihaloalkoxy; R 2 is, independently at each occurrence, halide, alkyl, perhaloalkyl, alkoxy, trihaloalkoxy, aryloxy, carboxy, ester, or NR 4 CO 2 R 5 ; and each of R 3 , R 4 , and R 5 is, independently at each occurrence, H, alkyl, aralkyl, aryl, ester, or amido wherein the FAAH mediated disorder is a painful syndrome, disease, or disorder.